Table 3.

Complication Profile

ComplicationTAS (%)CHG (%)P value
SSI4 (4.5)7 (8.0)0.35
 Minora2 (2.3)1(1.1)0.56
 Majorb2 (2.3)6 (6.8)0.15
 Explantationd2 (2.3)5 (4.5)0.25
Necrosisc20 (22.7)16 (18.2)0.45
Hematoma1 (1.1)2 (2.3)0.56
Seroma2 (2.3)3 (3.4)0.65
ComplicationTAS (%)CHG (%)P value
SSI4 (4.5)7 (8.0)0.35
 Minora2 (2.3)1(1.1)0.56
 Majorb2 (2.3)6 (6.8)0.15
 Explantationd2 (2.3)5 (4.5)0.25
Necrosisc20 (22.7)16 (18.2)0.45
Hematoma1 (1.1)2 (2.3)0.56
Seroma2 (2.3)3 (3.4)0.65

aRequired oral antibiotics. CHG, chlorhexidine; SSI, surgical site infection; TAS, triple antibiotic solution.

bRequired intravenous antibiotics, hospital admission, or incision and drainage/washout.

cFull or partial thickness.

dAn additional bilateral explant was performed secondary to development of persistent non-infectious rash.

Table 3.

Complication Profile

ComplicationTAS (%)CHG (%)P value
SSI4 (4.5)7 (8.0)0.35
 Minora2 (2.3)1(1.1)0.56
 Majorb2 (2.3)6 (6.8)0.15
 Explantationd2 (2.3)5 (4.5)0.25
Necrosisc20 (22.7)16 (18.2)0.45
Hematoma1 (1.1)2 (2.3)0.56
Seroma2 (2.3)3 (3.4)0.65
ComplicationTAS (%)CHG (%)P value
SSI4 (4.5)7 (8.0)0.35
 Minora2 (2.3)1(1.1)0.56
 Majorb2 (2.3)6 (6.8)0.15
 Explantationd2 (2.3)5 (4.5)0.25
Necrosisc20 (22.7)16 (18.2)0.45
Hematoma1 (1.1)2 (2.3)0.56
Seroma2 (2.3)3 (3.4)0.65

aRequired oral antibiotics. CHG, chlorhexidine; SSI, surgical site infection; TAS, triple antibiotic solution.

bRequired intravenous antibiotics, hospital admission, or incision and drainage/washout.

cFull or partial thickness.

dAn additional bilateral explant was performed secondary to development of persistent non-infectious rash.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close